Evonik publishes Q2 2026 company presentation, raises full-year adjusted EBITDA outlook to €2-2.2 billion

• Evonik raised FY 2026 adjusted EBITDA guidance to EUR 2-2.2 billion, up from a previous EUR 1.7-2 billion range.
• Q2 adjusted EBITDA rose 24% year over year to EUR 630 million, driven by stronger Advanced Technologies performance.
• Q2 free cash flow turned positive at EUR 49 million versus EUR -211 million a year earlier; H1 free cash flow improved to EUR 232 million from EUR -16 million.
• Free cash flow conversion target reaffirmed at about 40%; FY 2025 dividend set at EUR 1 per share.
• Cost program extended to 2029, targeting an additional 3,200 full-time job cuts.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evonik Industries AG published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.